Your browser doesn't support javascript.
loading
Lack of Mutations in POT1 Gene in Selected Families with Familial Non-Medullary Thyroid Cancer.
Orois, Aida; Badenas, Celia; Reverter, Jordi L; López, Verónica; Potrony, Miriam; Mora, Mireia; Halperin, Irene; Oriola, Josep.
Affiliation
  • Orois A; Department of Endocrinology and Nutrition, ICMDM, Hospital Clinic de Barcelona, C/Villarroel 170, 08036, Barcelona, Spain. aorois@clinic.cat.
  • Badenas C; Department of Endocrinology and Nutrition, Hospital Universitari Mútua de Terrassa, 08221, Terrassa, Spain. aorois@clinic.cat.
  • Reverter JL; Department of Biochemistry and Molecular Genetics, CDB, Hospital Clínic de Barcelona, 08036, Barcelona, Spain.
  • López V; Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), 08036, Barcelona, Spain.
  • Potrony M; Centro de Investigación Biomédica en Red de Enfermedades Raras (CIBERER), Instituto de Salud Carlos III (ISCIII), 28029, Madrid, Spain.
  • Mora M; Department of Endocrinology and Nutrition, Germans Trias i Pujol Health Science Research Institute and Hospital, Universitat Autònoma de Barcelona, 08196, Badalona, Spain.
  • Halperin I; Department of Biochemistry and Molecular Genetics, CDB, Hospital Clínic de Barcelona, 08036, Barcelona, Spain.
  • Oriola J; Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), 08036, Barcelona, Spain.
Horm Cancer ; 11(2): 111-116, 2020 04.
Article in En | MEDLINE | ID: mdl-32172474
ABSTRACT
To date, the genes involved in familial non-medullary thyroid cancer (FNMTC) remain poorly understood, with the exception of syndromic cases of FNMTC. It has been proposed that germline mutations in telomere-related genes, such as POT1, described in familial melanoma might also predispose individuals to thyroid cancer, requiring further research. We aimed to identify germline mutations in POT1 in selected FNMTC families (with at least three affected members) without a history of other cancers or other features, and to describe the clinical characteristics of these families. Sequencing of the 5'UTR and coding regions of POT1 was performed in seven affected people (index cases) from seven families with FNMTC. In addition, we performed whole-exome sequencing (WES) of DNA from 10 affected individuals belonging to four of these families. We did not find germline variants of interest in POT1 by Sanger sequencing or WES. We neither found putative causative mutations in genes previously described as candidate genes for FNMTC in the 4 families studied by WES. In our study, no germline potentially pathogenic mutations were detected in POT1, minimizing the possibilities that this gene could be substantially involved in non-syndromic FNMTC.
Subject(s)
Key words

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Telomere-Binding Proteins / High-Throughput Nucleotide Sequencing / Thyroid Cancer, Papillary Type of study: Clinical_trials / Prognostic_studies Limits: Adult / Female / Humans / Male / Middle aged Language: En Journal: Horm Cancer Year: 2020 Document type: Article Affiliation country: Spain

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Telomere-Binding Proteins / High-Throughput Nucleotide Sequencing / Thyroid Cancer, Papillary Type of study: Clinical_trials / Prognostic_studies Limits: Adult / Female / Humans / Male / Middle aged Language: En Journal: Horm Cancer Year: 2020 Document type: Article Affiliation country: Spain